She is a Medical Biotechnologist with a specialization in Virology and Microbiology obtained at the University of Turin. She worked for 7 years in the Clinical Pharmacology Laboratory of the Amedeo di Savoia Hospital, where she developed and validated chromatographic methods using UHPLC and HPLC instruments applied in pharmacokinetic studies for the analysis of several drugs and small molecules in different biological matrix. In 2017 she joined Merck company in Ivrea where she worked first in the LC-MS laboratory and from 2019 in the Formulation department laboratory, conducting GLP studies for the preparation and HPLC analysis of formulates for the in-vivo studies.

Close

Close

She is Head of Bioanalysis (small molecules) at Accelera srl since 2017. She is also core member of the European Bioanalytical Forum since 2016. She received her MSc degree in Biology and then she specialized in Biotechnology Applications at the University of Torino (Italy). In 2008 she joined Accelera srl, (NMS group) a contract research organization that provides drug development services to biotech, pharmaceutical companies and non-profit organizations at a global level. She has built expertise in providing LC-MS/MS bioanalytical support to preclinical and clinical studies conducted under GLP/GCP guidelines. Between 1999-2008 she worked as application specialist in Applied Biosystems, a private company operating in the life science field. Her main task was to deliver training courses on chromatography and mass spectrometry in southern Europe

Close

She has got her Master’s Degree in Chemistry and Pharmaceutical Technology at the University of Padua and spent more than 19 years working in metabolite profiling field. During her career she worked for GSK, APTUIT, and she is actually a Research Expert for the ADMET & Bioanalitycal Sciences department. Ellenia has an extensive knowledge and background in the structural elucidation of metabolites in several biological matrices, generated from in vitro and/or in vivo studies conducted with or without radio-labelled drugs, by using liquid chromatography coupled with high resolution mass spectrometry. She is accountable for the scientific supervision of the metabolite identification activities and, in particular, for the metabolites in safety testing (MIST) strategy to evaluate human metabolism during clinical trials.

Close

He is Head of Small Molecule Bioanalytical Sciences at F. Hoffmann-La Roche (Basel, Switzerland) since 2013. He received his MSc Degree in Chemistry from the University of Padova in 1992. Before joining F. Hoffmann-La Roche, he spent seventeen years at GlaxoSmithKline where he held roles of increasing responsibility and became Head of Bioanalysis at the Italian R&D Site in 2001. In 2010 he joined Aptuit Verona S.r.l. as Head of Bioanalysis. He possesses an excellent understanding of LC-MS, bioanalytical method development and validation, GxPs and current global bioanalytical guidance. He is author of several scientific papers and speaker at numerous conferences.

Close

He is Vice President at the ADMET & Bioanalytical Sciences Laboratory of Aptuit (Evotec company) in Verona (Italy) and he is also a member of European Bioanalytical Forum. Alessandro obtained his M.Sc. in Chemistry at the University La Sapienza in Rome. About twenty years of experience in the bioanalytical field with particular focus on liquid chromatography and mass spectrometry. He is responsible to coordinate and manage ADMET, LC-MS and Immunoassay laboratories. He is involved in the coordination of regulated bioanalytical activities supporting preclinical and clinical studies and project teams. Prior to joining Evotec, Alessandro worked as Team Leader in the Bioanalytical Laboratory at GlaxoSmithKline in Verona (Italy).

Close

She graduated in Biology applied to the biomedical research at the university of Varese - Insubria, with a thesis in neuro-psychopharmacology. She joined Accelera S.r.l (NMS Group) in 2011, to conduct her thesis for the Master in Pharmacy and Oncological Pharmacology. From 2013 she works in Accelera Drug Disposition laboratory taking responsibility of regulated and non-regulated ADME studies, to support both discovery and development projects. She was mainly involved in in vivo activities with radiolabeled drugs like pharmacokinetics, excretion and tissue distribution studies, developing a specific expertise in the field of autoradiography technique (WBA).

Close

He is Certified Consultant of LabWare in Verona (Italy). Federico obtained his M.Sc. in Chemistry at the University La Sapienza in Rome. He has about twenty years of experience, as Senior Study Director and Expert of Mass Spectrometry, in the bioanalytical field with a particular love for micro liquid chromatography coupled with high resolution MS, computerized system validation and laboratory data management in RTC (Rome) and then in ERBC (Rome). He was responsible for new method development for metabolism and drug-drug interaction services. He then decided to dedicate this new working experience to the LabWare LIMS configuration and implementation in different analytical laboratories extending his knowledge of the analytical processes.

Close

He is a pharmaceutical chemist with strong competence in mass spectrometry with more than 20 years of experience in LC-MS and GC-MS techniques applied to small molecule and biopolymer (DNA, protein, antibodies). He holds a Laurea degree in organic chemistry and a Ph.D. in pharmaceutical chemistry from Milan University. Federico is currently working in Merck KGaA as Head of NBE-DMPK Innovative Bioanalytics. The department is focused on supporting NBE projects including the development and validation of new bioanalytical methods used to support preclinical studies (PK/TK). He was the author of more than 20 scientific publications.

Close

She is Bionalytical Scientific Manager and Clinical Innovation lead at UCB Biopharma SRL (Brussels, Belgium). She received her MSc Degree in Chemistry from the University of Pavia in 1999. Afterwards, she spent ten years in different pharma companies and biotech (Pharmacia, GlaxoSmithKline, Cell Therapeutics) in the bioanalytical departments where she held roles of increasing responsibility. In 2009 she joined UCB Biopharma SRL as Head of Discovery Bioanalysis (Belgium site) and in 2015 she became Bioanalytical Scientific Manager. In addition to her role, she recently joined the clinical innovation team as Clinical Innovation Lead to set up and implement patient centric sampling strategy to allow decentralised clinical trials.

Close

She met the Mass Spectrometry during her thesis in Organic Chemistry at the University of Pavia and never stopped working in that field since then. She had the opportunity to work in several pharmaceutical companies in Analytical Department group and as a support to research group always using Mass Spectrometry. She started with Bracco in 1996 using an ion trap to characterise synthetic compounds, move then to Zambon in 1998 to coordinate different activities in both analytical research and development but spent about 10 years in the company that was Pharmacia &Upjohn at the begininning and now is Nerviano Medical Sciences. When in P&U she met the HRMS used mainly to support the impurity profile among many other activities. In 2004 she decided to change her view and move to work in Waters as High-Resolution Mass Spectrometry (HRMS) specialist supporting customers in different application areas (from Met ID, to ADC characterization through small molecule structural ID).

Close

She is currently Head of DMPK & Bioanalytical Unit of Menarini Ricerche S.p.A. She has extensive experience as Senior Study Director / Principal Investigator in both preclinical and clinical bioanalytical chemistry according to GLP and GCP procedures and is a member of the European Bioanalytical Forum. She received her MSc in Chemistry from the University of Rome "La Sapienza" in 1997. She has spent her entire professional life in the bioanalytical field, with particular reference to the use of chromatographic systems with traditional detectors and mass spectrometers. She worked first at the "Bambino Gesù" pediatric hospital in Rome and then in Menarini Ricerche in a GLP and GCP regulated environment.

Close

Full professor of Forensic Medicine and Science at the University of Verona and vice director of the Pharmacokinetics and Metabolomics Laboratory, IM Sechenov University, Moscow. Associate editor of "Medicine Science and The Law". Ad hoc consultant of UNDCP (United Nations International Drug Control Program, Vienna) and member of the International Panel of Forensic Experts of UNODC (United Nations Office on Drugs and Crime, Vienna). Publications: more than 200 articles in extenso in international or national journals and books with international and national publisher (H-index = 39).

Close

Degree in Pharmaceutical Chemistry (CTF) and Certified as Pharmacist at Università degli Studi di Padova. She has more than 15 years of experience in the Pharmaceutical Industry performing different roles in different regulated environments. She started in GMP quality assurance in GlaxoSmithKline Manufacturing as a microbiological specialist and then as a filling expert acquiring knowledge of GMP regulations applied to the production of cephalosporin for injection in a sterile environment. After two years she moved to the Bioanalytical department of GlaxoSmithKline R&D where she worked in a GLP environment, moving then to GLP/GCP QA. She now has the role of Manager of GLP/GCP quality assurance in Aptuit, an Evotec Company, responsible for all Quality Assurance GLP and GCP activities. Her responsibilities range from assuring Test Facility Management of compliance with GLP/GCP principles to provide regulatory support to the Business operations, to manage the validation of computerized systems, host Client and Regulatory inspections, collect and trend quality metrics.

Close